143 related articles for article (PubMed ID: 1380423)
1. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease.
Yacyshyn BR; Pilarski LM
Gut; 1993 Dec; 34(12):1698-704. PubMed ID: 7506695
[TBL] [Abstract][Full Text] [Related]
3. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.
Yacyshyn BR; Meddings JB
Gastroenterology; 1995 Jan; 108(1):132-7. PubMed ID: 7528696
[TBL] [Abstract][Full Text] [Related]
4. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
[TBL] [Abstract][Full Text] [Related]
6. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
7. B1a Lymphocytes (CD19+CD5+) Deficiency in Patients with Crohn's Disease and Its Relation with Disease Severity.
Gil-Borras R; García-Ballesteros C; Benet-Campos C; Catalán-Serra I; López-Chuliá F; Cuéllar C; Andreu-Ballester JC
Dig Dis; 2018; 36(3):194-201. PubMed ID: 29421816
[TBL] [Abstract][Full Text] [Related]
8. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the expression of CD5 by human B cells and correlation with functional activity.
Vernino LA; Pisetsky DS; Lipsky PE
Cell Immunol; 1992 Jan; 139(1):185-97. PubMed ID: 1370255
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
Selby WS; Jewell DP
Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
[TBL] [Abstract][Full Text] [Related]
11. [Circulating lymphocyte subpopulations in patients with Crohn's disease].
Sauer D; Sauer H; Fiebig H
Gastroenterol J; 1991; 51(1):27-32. PubMed ID: 1910492
[TBL] [Abstract][Full Text] [Related]
12. Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.
Auer IO; Götz S; Ziemer E; Malchow H; Ehms H
Gut; 1979 Apr; 20(4):261-8. PubMed ID: 312753
[TBL] [Abstract][Full Text] [Related]
13. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
Paglieroni T; MacKenzie MR; Caggiano V
Ann N Y Acad Sci; 1992 May; 651():486-7. PubMed ID: 1376067
[No Abstract] [Full Text] [Related]
15. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis.
Mix E; Olsson T; Correale J; Baig S; Kostulas V; Olsson O; Link H
Clin Exp Immunol; 1990 Jan; 79(1):21-7. PubMed ID: 1689227
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
[TBL] [Abstract][Full Text] [Related]
17. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study.
Lynch EF; Jones PA; Swerdlow SH
Cytometry; 1995 Sep; 22(3):223-31. PubMed ID: 8556954
[TBL] [Abstract][Full Text] [Related]
18. Alterations of peripheral blood CD5+ B cells in inflammatory bowel disease.
Mishima Y; Ishihara S; Amano Y; Oshima N; Kadota C; Otani A; Moriyama I; Li YY; Aziz MM; Kinoshita Y
Scand J Gastroenterol; 2009; 44(2):172-9. PubMed ID: 18830898
[TBL] [Abstract][Full Text] [Related]
19. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
